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Abstract
Mutations of the huntingtin protein (HTT) gene underlie both adult-onset and juvenile forms
of Huntington’s disease (HD). HTT modulates mitotic spindle orientation and cell fate in
mouse cortical progenitors from the ventricular zone. Using human embryonic stem cells
(hESC) characterized as carrying mutations associated with adult-onset disease during
pre-implantation genetic diagnosis, we investigated the influence of human HTT and of an
adult-onset HD mutation on mitotic spindle orientation in human neural stem cells (NSCs)
derived from hESCs. The RNAi-mediated silencing of both HTT alleles in neural stem cells
derived from hESCs disrupted spindle orientation and led to the mislocalization of dynein,
the p150Glued subunit of dynactin and the large nuclear mitotic apparatus (NuMA) protein.
We also investigated the effect of the adult-onset HD mutation on the role of HTT during
spindle orientation in NSCs derived from HD-hESCs. By combining SNP-targeting allele-
specific silencing and gain-of-function approaches, we showed that a 46-glutamine expan-
sion in human HTT was sufficient for a dominant-negative effect on spindle orientation and
changes in the distribution within the spindle pole and the cell cortex of dynein, p150Glued
and NuMA in neural cells. Thus, neural derivatives of disease-specific human pluripotent
stem cells constitute a relevant biological resource for exploring the impact of adult-onset
HD mutations of the HTT gene on the division of neural progenitors, with potential applica-
tions in HD drug discovery targeting HTT-dynein-p150Glued complex interactions.
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Introduction
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder caused by
abnormal extension of a tract of CAG repeats in the first exon of the HTT gene [1]. Mutated
forms of the huntingtin (HTT) protein carry an extended stretch of glutamine residues
(polyQ) close to the N-terminus [2]. The mean size of the CAG expansion is 18 repeats in the
general population, but patients with HD carry expansions including more than 35 CAG
repeats. Most forms of HD patients have an onset during adulthood. For such forms, the lon-
gest CAG expansion of the twoHTT alleles contains 41 to 48 repeats, with a mean of 44 CAG
repeats [3], [4], [5]. The affected patients are clinically characterized by psychiatric, cognitive
and motor disturbances beginning between the ages of 35 and 50 years. Early onset of the
symptoms, high severity and rapid disease progression are associated with the presence of
larger numbers of CAG repeats [6]. Fewer than 10% of patients develop symptoms before the
age of 20 years; this juvenile form of the disease is characterized by a more widespread and rap-
idly progressing pattern of brain degeneration associated with a larger number (> 60) of CAG
repeats than for adult-onset HD [7].
HTT is a large scaffold protein involved in diverse cellular functions in multiple cellular
compartments [8]. HTT interacts with hundreds of protein partners. It interacts directly with
dynein and indirectly with dynactin, through huntingtin-associated protein 1 (HAP-1), which
binds to p150Glued. This complex regulates the microtubule-dependent transport of organelles
in neurons [9], [10] and ciliogenesis [11], and ensures the correct orientation of the mitotic
spindle, thereby regulating cell fate [12], [13]. Current knowledge of the pathological processes
involved suggests that neuron loss in HD results from both a loss of wild-type HTT (wtHTT)
functions and the gain of new toxic functions by the mutant HTT protein (mutHTT), probably
acting in both cell-autonomous and non-autonomous manners [14].
Most of the genetic mouse and cellular models used to study the impact of HTT mutations
express mutHTT fragments or full-length mutHTT with particularly long polyQ stretches
encoded by expansions of more than 100 CAG repeats. The extent to which “acute” models of
this kind can accurately replicate the decades-long pathological processes resulting from the
most common types of HD mutations (41–48 CAGs) observed in the brains of patients is diffi-
cult to ascertain. Technologies providing access to human pluripotent stem cells (hPSCs) [15]
have made it possible to develop new disease models based on hPSC derivatives that could
potentially bridge this gap and improve our understanding of HD pathogenesis. A number of
disease-specific (i.e. mutant) hPSC lines have been obtained from embryos found to carry
mutations during a pre-implantation genetic diagnosis procedure or from somatic cells from
patients. Several of these lines carry CAG repeats of lengths known to be associated with the
adult-onset form of the disease and corresponding to the most common form of HD mutation.
Such HD-hPSC lines have been used to decipher the impact of adult- or juvenile-onset HD
mutations of theHTT gene in human cells [16], [17], [18], [19], [20], [21].
HTT regulates the division of mouse embryonic cortical progenitors and mammary stem
cells [13], [12]. The consequences of HTT mutation for cell division of neuronal progenitors
have recently been deciphered in the context of embryonic cortical development, in a mouse
genetic model carrying an HTTmutation with an expansion of more than 100 CAG repeats
[22]. In this study, we combined the use of neural derivatives of wild-type (WT) and adult-
onset HD-hESCs and SNP-targeting HTT allele-specific mRNA interference to investigate the
role of human HTT in the division of neural progenitors and to determine whether an adult-
onset HD mutation affects this function.
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Materials and Methods
Cell culture
Neural cells were derived from H9 (WT XX, passages 40–60, WiCell Research Institute) [15],
SIVF018 (XX, 46 CAG, passage 18–30, Sydney IVF Stem Cells, Australia) [23] and SA01 (WT
XY, passages 12, CellArtis AB, Göteborg, Sweden) [24] embryonic stem cell lines, as previously
described in [25]. Neural stem cells (NSC) obtained from hESCs were maintained on poly-L-
ornithine and laminin (Sigma, St. Louis, Missouri, USA) coated plates until passage 29 and
then discarded. Cells were harvested with 0.05% trypsin-EDTA (Invitrogen, Cergy Pontoise,
France) and seeded at 100x103 cells/cm2 in culture plates. NSC were cultured in 1:1 ratio of
Neurobasal: DMEM/Hams’s F-12 (Invitrogen, Cergy Pontoise, France), supplemented with
0.1% penicillin/streptomycin, 0.1% β-mercaptoethanol (Sigma-Aldrich), 1% B27 (Invitrogen,
Cergy Pontoise, France), 0.5% N2 (Invitrogen, Cergy Pontoise, France), supplemented with 10
ng/mL of basic fibroblast growth factor (FGF-2) (Invitrogen, Cergy Pontoise, France) and 10
ng/mL epidermal growth factor (EGF) (R&D systems, Minneapolis, USA). Cells were plated in
multiwell plates 54 hr before synchronization using RO-3306 (10 μM, for 18 hr) (Enzo Life Sci-
ences, France). The population was released from the G2 block by three washes with pre-
warmed drug-free media and incubation with fresh media (30 min).
Plasmids and siRNA
Genotypes on exon 50 for SNP rs362331 of H9 and SIVF018 NSC lines were analysed by
sequencing the PCR product encompassing this SNP generated using the following primers:
5’-CCCCAAACGAAGGTACACGA-3’ and 5‘- CCTGTTGGCCATCTCTCACC-3’. SIVF018
NSC line is heterozygous at SNP rs362331 (C/T), while H9 is homozygous (T/T) (S1A Fig).
shRNAs targeting these SNP (si50C, si50T) were designed as previously described [16]. The
SIN-CWP-GFP-LTR(N)-TRE-si1.1 (complete knock-down, shHTT1.1.), SIN-CWP-GFP-LTR
(N)-TRE-si50T (50T allele-specific, shHTT50T), SIN-CWP-GFP-LTR(N)-TRE-si50C (50C
allele-specific, shHTT50C) and SIN-CWP-GFP-LTR(N)-TRE-siUNIV (shcontrol) plasmids
were previously described [16]. The plasmids encoding N-terminal fragments of wild-type
(23Q; mCherry-HTT-N586-23Q) and polyQ HTT (100Q; mCherry-HTT-N586-100Q) con-
structs were previously described [26].
Transfection
Prior to nucleofection, cells were harvested with trypsin; 5x106 cells were nucleofected using
the Amaxa Rat NSC Nucleofector Kit (Lonza) according to the manufacturer protocol. NSC
were resuspended in 100 μL of nucleofection solution with 5 μg of DNA and 0.5 μg of
pmaxGFP Vector or 1.5 μg (1 μM) of siRNA and electroporated with the Amaxa Nucleofector
Program A-033 (Lonza) before plating on poly-ornithine/laminin coated dishes. For shRNA
nucleofection, five million NSC resuspended in 100 μL of nucleofection solution of the
Amaxa1 Rat NSC Nucleofector1 Kit (Lonza) with 5 μg of shRNA (1 μM) were electroporated
with the Amaxa Nucleofector Program A-033 (Lonza) before plating on poly-ornithine/lami-
nin coated dishes. All cells were incubated in humidified 37°C/5% CO2 incubator and medium
was changed after 24 hr.
RNA extraction and Quantitative RT-PCR
Total RNA from NSC cells was extracted using RNeasy Mini Spin Columns (Qiagen, Courta-
boeuf, France). The purified RNA was quantified with NanoDrop ND-1000A spectrophotome-
ter. Transcription was performed on 500 ng of RNA using Cloned AMV First-Strand cDNA
Huntington Disease and Cell Division
PLOS ONE | DOI:10.1371/journal.pone.0148680 February 10, 2016 3 / 16
Synthesis Kit (Invitrogen, Cergy Pontoise, France). cDNA synthesis was performed using total
RNA primed with oligo(dT) (50 μM)mixed with RandomHexamers (50 ng/μL) according to
manufacturer’s protocol. Quantitative real time-polymerase chain reactions (QRT-PCRs) are
performed with Power SYBRGreen PCRMix and a LC480 system (Roche, Boulogne-Billancourt,
France). Quantification was performed at a threshold detection line (Ct value). The Ct of each
target gene was normalized to the 18S housekeeping gene. For primer sequences see S1 Table.
HTTmRNA allelic ratio analysis was performed using TaqMan SNP Genotyping Assays
(Hs00918153_m1: Applied Biosystems, Foster City, CA, USA) on cDNA used for QRT-PCR.
The median of difference of Ct of each target allele (3 technological replicate) was used to cal-
culate theHTT allelic ratio expressed in % of SNP50C and SNP50T in allHTTmRNA (geno-
mic DNA was used as a control sample with 50%/50% HTT allelic ratio).
For the CAG repeats size analysis, a PCR was performed using TaKaRa LA Taq DNA Poly-
merase with GC Buffers (Takara Bio, Madison, USA), according to manufacturer protocol, on
cDNAs obtained from allele-specific cDNA synthesis using specific primers for HTT exon 1
50-AAGGCCTTCGAGTCCCTCAA-3’ and 5’-CACACGGTCTTTCTTGGTAGC-3’. The
expected amplicon size for a normal allele with 23 CAG repeats is 281bp. The PCR products
were analysed by the Bioanalyser 2100 (Agilent, CA, USA) using microfluidic chips which
were prepared according to manufacturer’s instructions. Analysis of the data was performed
using Data Review software version A.01.20 Sl211 and presented in the form of electrophero-
grams or alternatively as a list of calculated band sizes.
Immunofluorescence
To visualize spindles, cells were permeabilized with PHEM/0.5% Triton X-100 for 30 sec, then
fixed with 4% PAF/PHEM (20 min at RT) and with methanol at -20°C (5 min). Cells were
rehydrated with PBS/0.1% Triton X-100 (3 washes), blocked in 10% Normal Goat Serum
(NGS)/PBS (30 min) and incubated with the following antibodies: anti-γ-tubulin (1:500, T3320
or 1:100, 6557; Sigma-Aldrich); anti-p150Glued (1:100, 610474; BD Transduction Laboratories);
anti-736-HTT (1:300; [27]); anti-NuMA (1:500; Novus biological).
For dynein intermediate chain (DIC) staining (1:200; mAB 1618 Chemicon) the fixation
procedure was as follows: cells were immersed in microtubule stabilizing buffer (MTSB: 4 M
glycerol, 100 mM PIPES, pH 6.8, 1 mM EGTA, 5 mMMgCl2) for 2 min, followed by extraction
for 2 min in MTSB/0.5% Triton X-100. Cells were then fixed for 3 min with methanol at -20°C.
For all immunostainings, the slides were counterstained with DAPI (Roche, Boulogne-Bil-
lancourt, France) and mounted in Mowiol. The images were captured either with a three-
dimensional deconvolution imaging system or with a Leica DM RXAmicroscope equipped
with a 63x oil-immersion objective coupled to a piezzo and a Micromax RTE/CDD-1300-Y/HS
camera controlled by Methamorph software (Molecular Devices). Z-stack steps were of 0.3 μm.
Images were treated with ImageJ (http://rsb.info.nih.gov/ij/, NIH, USA).
Spindle Orientation Quantification and Image Analyses
Spindle orientation in metaphase cells stained for γ-tubulin and DAPI to visualize the spindle
poles and chromatin was quantified using ImageJ software (http://rsb.info.nih.gov/ij/, NIH,
USA). A line crossing both spindle poles was drawn on the Z projection pictures and reposi-
tioned along the Z-axis using the stack of Z-sections. The angle between the pole-pole and the
substratum plane was calculated by the ImageJ Plug-in. Spindle lengths and cell lengths were
quantified along the line that crosses both spindle poles. In rescue experiments, cells that were
positive for mCherry (thus expressing N-terminal fragments of wild-type and mutant HTT)
were analysed for spindle orientation.
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The quantification of p150Glued and DIC at spindle poles was achieved with 3D object
counter plugin ([28]; http://imagej.nih.gov/ij/plugins/track/objects.html). A circle (radius
equal to half of pole-pole distance) was drawn around the pole position, and image was cleared
outside the circle. Total volume and intensity of the particles were retrieved for further
analysis.
Quantification of NuMA at spindle pole was performed on the resulting z-stacks (one for
each pole) using JACoP plugin (http://imagej.nih.gov/ij/plugins/track/jacop.html) which deter-
mines the localization of NuMA at spindle poles given by γ-tubulin. Manders' overlap coeffi-
cient corresponds to the co-localization between both images.
Immunoblotting
Cells were lysed 72 h after transfection (lysis buffer: 50 mM Tris-HCl pH 7.5, 0.1% Triton X-
100, 2 mM EDTA, 2 mM EGTA, 50 mMNaF, 10 mM β-glycerophosphate, 5 mM sodium
pyrophosphate, 1 mM sodium orthovanadate, 0.1% (v/v) β-mercaptoethanol, 250 μM PMSF,
and 10 mg/ml aprotinin and leupeptin). Twenty five μg of proteins were loaded in 6% gel, sub-
jected to SDS-PAGE and electrophoretically transferred to Protran nitrocellulose membranes
fromWhatman. Blots were blocked in 5% BSA/TBST buffer (20 mM TrisHCl, 0.15 M NaCl,
0.1% Tween 20) and incubated with anti-dynein intermediate chain (DIC, 1:500; Millipore Bio-
science Research Reagents), anti-HTT D7F7 (1:1000; Cell Signaling Technology), anti-polyQ
1C2 (1:5000; Euromedex), anti-NuMA (1:1000; Novus biological), anti-p150Glued (1:1000; BD
Transduction laboratories) and anti-α-tubulin (1:1000; Sigma) antibodies, for 1 hr.
Primary polyclonal antibodies used were: anti-PAR3 (1:1000), anti-PAR6 (1:500), anti-
aPKC (1:1000), anti-RAB11A (1:500) and anti-mCherry (1:1000; Institut Curie, Paris).
Statistical Analyses
GraphPad Prism 5.0 software (San Diego, CA, USA) was used for statistical analysis. Data are
expressed as mean ± SEM of the indicated number of independent experiments. Statistical sig-
nificance was analysed using parametric tests, namely Student’s t-test and one way-ANOVA.
Results
Human HTT regulates spindle orientation in dividing neural stem cells
derived from human embryonic stem cells
We used NSCs differentiated from control human embryonic stem cells (the H9 line) and plas-
mids encoding a short hairpin RNA (shRNA) directed against HTT (shHTT1.1) or a control
shRNA (shControl) to study the effect of HTT knockdown (Fig 1A) [19]. HTT protein levels
on western blots were 70% ± 16.18 (n = 3) lower in H9-derived WT-NSC 72 hours after trans-
fection with the shHTT1.1 plasmid (Fig 1B). During mitosis, the polyclonal antibody (pAb)
against HTT (763) labeled HTT at the spindle poles, as previously described (Fig 1C). HTT
was also detected in the cell cortex. Treatment with shHTT1.1 significantly decreased the signal
intensity at the spindle pole and resulted in the dispersion of HTT from its cortical location. In
shHTT1.1 conditions, remaining HTT appeared more disperse in the cytoplasm forming larger
punctae of unknown nature.
We then carried out immunostaining with an anti-γ-tubulin antibody, of H9-derived
WT-NSCs transfected with shControl or shHTT1.1 plasmids, for analysis, in Z-series stacks
(ΔZ> 1.8 μm), of the position of the spindle poles with respect to the substratum plane (Fig
2A and 2B). Spindle orientation was determined in metaphase cells, by measuring the angle
between the pole-pole axis (the axis of the metaphase spindle) and the substratum plane. Non-
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transfected WT-NSCs and WT-NSCs transfected with shControl had a significantly smaller
mean angle (7.6° ± 0.7, n = 86; 8.1° ± 0.9, n = 65, respectively) than shHTT1.1-treated cells
(18.9° ± 2.1, n = 74) (Fig 2B). The proportion of metaphase cells with an angle greater than 10°
was higher in shHTT1.1-transfected WT-NSCs (79.5%) than in control cells (non-transfected
cells: 28%; shControl-treated cells: 30%). A large proportion of the cells treated with shHTT1.1
(30.1%) had spindle angles exceeding 20°.
These results were confirmed with an alternative RNA interference plasmid targeting the
rs362331 SNP in exon 50 of theHTT gene in the H9 genome (shHTT50T) (Fig 1A). The
Fig 1. Silencing of HTT in wild-type human neural stem cells. (A) Schematic representation of HTT. (B) Western blotting with anti-HTT and anti-α-tubulin
antibody of lysates of H9-derived NSC treated with shControl and shHTT1.1. The graph represents the quantitative assessments of the ratio of HTT over
tubulin in each condition (3 independent experiments). (C) Immunostaining of metaphase shControl and shHTT1.1-treated cells with anti-γ-tubulin and anti-
HTT antibodies and DAPI counterstaining. Nuclei are counterstained with DAPI. Scale bars, 5 μm. The graph represents the quantification of anti-HTT signal
at the spindle poles (n = 20 cells analysed in 3 independent experiments). Results are shown as the mean values ± SEM. **p<0.01; Student’s t-test.
doi:10.1371/journal.pone.0148680.g001
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genotyping of H9 cells revealed that the H9WT-hESC line was homozygous for the rs362331
SNP in exon 50 (T/T) (S1A Fig). We therefore transfected H9-derived WT-NSCs with
shHTT50T (S1B Fig), thereby targeting both alleles of HTT in H9-hESC derivatives.
H9-derived WT-NSCs treated with shControl had mean spindle angles of less than 10° (8.9° ±
Fig 2. Silencing of human HTT induces spindle misorientation in human NSC. (A) Schematic illustration of spindle angle measurement. (B-D) H9-hESC
derived neural stem cells were either non-treated or treated with shControl, shHTT1.1, shHTT50T or shHTT1.1+N586-HTT-Q23 as indicated. Distribution and
average of spindle angles of metaphase cells are shown. In B, cells were stained with anti-γ-tubulin and DAPI and Z-X projections are shown. (B) WT-NSC:
n = 86, shControl: n = 65, shHTT1.1: n = 74. (C) WT-NSC: n = 129, shControl: n = 108, shHTT50T: n = 32. (D) WT-NSC shHTT1.1 + pControl: n = 25,
WT-NSC shHTT1.1 + HTT-N586-23Q: n = 49. (E) Distribution of H9-derivedWT-NSC transfected with shControl and shHTT1.1 in prophase, metaphase and
ana/telophase (WT-NSC shControl: n = 353, WT-NSC shHTT1.1: n = 389). All data are from at least 3 independent experiments. Results are shown as the
mean values ± SEM. ***p<0.001; **p<0.01; Student’s t-test or one-way ANOVA.
doi:10.1371/journal.pone.0148680.g002
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0.7, n = 129; 7.4° ± 0.6, n = 106), whereas the mean angle in shHTT50T-treated WT-NSCs
exceeded 20° (22.4° ± 2.3, n = 32) (Fig 2C). In shHTT50T-treated cells, spindle angles were
more evenly distributed, with more than 33% of the metaphase cells having an angle greater
than 20°.
We then introduced a 586-amino acid N-terminal fragment of human HTT with 23 gluta-
mine residues (N586-HTTQ23) into WT-NSCs, to reproduce HTT function during mitotic
spindle orientation. The nucleotide sequence encoding this fragment was modified to ensure
that it was not targeted by shHTT1.1, which specifically targets endogenous humanHTT [26].
N586-HTTQ23 rescued the spindle orientation defect observed after HTT silencing in
WT-NSCs (Fig 2D).
We also analysed the distribution of cells across mitotic phases on the basis of chromosome
configurations. HTT-depleted and control WT-NSCs were distributed in a similar manner
across mitotic phases (Fig 2E). These findings indicate that human HTT regulates spindle ori-
entation with no effect on progression through the cell cycle in human neural stem cells.
HTT is required for the mitotic localization of dynein, dynactin and NuMA
in human NSCs
HTT associates with dynein/dynactin to stimulate axonal transport in neurons [9]. The silenc-
ing of mouse HTT in neuronal cells and mammary stem cells leads to mislocalization of
dynein, the p150Glued subunit of dynactin and the large nuclear mitotic apparatus protein
NuMA during mitosis, suggesting that HTT may act as a scaffold for these proteins, to ensure
correct spindle orientation [12], [13]. We immunostained H9-derived NSCs for the dynein
intermediate chain (DIC), the p150Glued subunit of dynactin and NuMA during mitosis (Fig 3).
All were present at the spindle poles and on the spindle, along astral microtubules and at corti-
cal sites (Fig 3A–3C). We assessed the dependence of these distributions on HTT, by silencing
the endogenous human HTT. When HTT was silenced, we did not observe obvious changes in
total levels of p150Glued, DIC and NuMA proteins (S1C Fig). The silencing of HTT in
WT-NSCs with the shHTT1.1 plasmid (Fig 1) resulted in the partial mislocalization of dynein
and p150Glued away from the spindle poles (Fig 3A–3C). By contrast, NuMA accumulated at
the spindle poles when HTT levels were decreased. In HTT-depleted human NSCs, lower levels
of dynein, p150Glued and NuMA were detected on the astral microtubules and in the cell cortex.
These data suggest that human HTT controls the correct distribution of several key mitotic
proteins, potentially influencing spindle orientation in humanWT-NSCs.
Human adult-onset HDmutations of the HTT gene have a dominant
negative effect on spindle orientation in HD-hESC-derived NSCs
We then investigated the effect of HD mutations on the role of HTT during spindle orientation
in dividing NSCs derived from hESCs. We first expressed a mutant 586-amino acid N-terminal
fragment of HTT with a large expanded polyQ stretch of 100 residues (N586-HTTQ100) in
WT-NSCs derived from H9-hESCs. WT-NSCs expressing N586-HTT-Q100 had a significantly
larger mean spindle angle than control cells (16.9° ± 1.3; n = 38 versus non-treated cells: 7.6° ±
0.7, n = 86 andWT-NSCs expressing an empty plasmid: 8.3#x00B0; ± 1, n = 51) (Fig 4A). In
particular, 78.4% of cells in metaphase expressing mutHTT had a spindle angle exceeding 10°.
We then used NSCs differentiated from a hESC line characterized as carrying oneHTT allele
with an adult-onset HD mutation during a pre-implantation genetic diagnosis procedure
(SIVF018 line). In this cell line, the longest CAG expansion contained 46 CAGs. The size of the
CAG expansion and the link between the mutated allele and the rs362331 SNP at exon 50
(50T) were confirmed (S1A Fig). The allelic ratio for HTT was determined with a Taqman
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probe specific for the rs362331-T and -C SNP in HD-NSCs nucleofected with siRNA targeting
the rs362331-T (siHTT50T) and rs362331-C (siHTT50C) SNPs. This confirmed that SNP-tar-
geting RNA interference could discriminate between the two alleles, as shown in a previous
study [16]. Total HTT expression (i.e both alleles), as assessed by RT-qPCR, was reduced by
Fig 3. Loss of HTT alters dynein, p150Glued, and NuMA localization in human NSC. Immunostainings of metaphasic neural stem cells with anti-DIC (A),
anti-p150Glued (B), anti-NUMA (C) and anti-γ-tubulin antibodies. Nuclei are counterstained with DAPI. Scale bars, 5 μm. Graphs correspond to the
quantifications of (A): shControl: n = 52 and shHTT1.1: n = 60; (B): shControl: n = 57 and shHTT1.1: n = 60; (C): shControl: n = 22 and shHTT1.1: n = 22 cells
analysed in at least 3 independent experiments. Results are shown as mean values ± SEM. ***p<0.001; **p<0.01; Student’s t-test.
doi:10.1371/journal.pone.0148680.g003
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Fig 4. Allele-specific silencing rescues spindle misorientation in NSC derived from HD-hESC. (A) H9-hESC derived neural stem cells were either non-
electroporated (WT-NSC) or electroporated as indicated. Distribution and average of spindle angles of metaphase cells are shown. WT-NSC: n = 86,
WT-NSC shControl: n = 51, WT-NSC HTT-N586-100Q: n = 38 cells were analysed. (B)HTT allelic ratio measured by RT-qPCR in SIVF018-hESC derived
HD-NSCs transfected as indicated every 48 hours; mRNAs were collected at day 7. (C) Distribution of shControl and shHTT50T-treated SIVF018 HD-NSC in
prophase, metaphase and ana/telophase. shControl: n = 629, shHTT50T n = 402 cells were analysed. (D, E) SIVF018 HD-NSCs were either non-
electroporated or electroporated as indicated. Distribution and average of spindle angles of metaphase cells are shown. (D): SIVF018: n = 83, shControl:
n = 61, shHTT50T: n = 68. (E) SIVF018: n = 83, shControl: n = 61, HTT N586-23Q: n = 29 cells were analysed. (F) SIVF018 HD-NSCs were non-
electroporated or electroporated as indicated. Distribution and average of spindle angles of metaphase cells are shown. SIVF018: n = 83, shControl: n = 61,
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35.3% ± 1.4 (n = 4) in SIVF018-derived NSCs after transfection with the siHTT50T plasmid,
and by 24.60% ± 2.8 (n = 4) in SIVF018-derived NSCs after transfection with the siHTT50C
plasmid (Fig 4B). In agreement, total HTT and mutant HTT protein levels were decreased
(S1D and S1E Fig).
The expression of a mutant HTT fragment leads to a defect in spindle orientation resem-
bling the loss of function in WT-NSCs (Figs 2B and 4A). We therefore assessed whether the
allele-specific silencing of mutant HTT was associated with a recovery of function. The treat-
ment of SIVF018 HD-NSCs with shHTT50T had no effect on progression through the cell
cycle (Fig 4C). We then compared spindle angles in untreated, and shControl- or shHTT50T-
treated SIVF018 cells. Untreated and shControl-treated SIVF108 HD-NSCs had spindle angle
distributions and mean spindle angles consistent with the loss of function (19° ± 1.2, n = 83;
16.8° ± 1.5, n = 61) (Fig 4D; see also Fig 2). By contrast, most shHTT50T-treated SIVF018 cells
divided with a spindle angle of less than 10°, and the mean spindle angle was similar to that in
wild-type cells (9.5° ± 1, n = 68). We also expressed a wild-type HTT fragment
(N586-HTT-Q23) in mutant cells, but this fragment had no effect on the distribution of spindle
angles or on the mean spindle angle in the mutant cells (Fig 4E). In SIVF018 NSCs transfected
with shHTT50C, spindle angle was similar to that in controls (Fig 4F). These results indicate
that a limited expansion of the N-terminal polyglutamine tract in HTT similar to that found in
most patients with adult-onset HD is sufficient to induce a dominant-negative effect on spindle
orientation. Furthermore, allele-specific silencing of mutant HTT in HD cells was found to be
associated with a recovery of function during spindle orientation.
Recovery of dynein, p150Glued and NuMA localization after mutant HTT
allele-specific silencing
We then investigated whether the functional rescue of spindle orientation induced by the
shHTT50T treatment of SIVF018 HD-NSC affected the localization of dynein, p150Glued and
NuMA. Cells were treated with shControl and shHTT50T and immunolabeled for these pro-
teins (Fig 5). In mutant cells treated with the control construct, the patterns of staining for
dynein, p150Glued and NuMA were approximately similar to those in wild-type neural cells in
which HTT was silenced (compare Figs 3 and 5). In mutant cells treated with shHTT50T, the
localization of these proteins was restored to that observed in WT-NSCs. Indeed, there was
more dynein and p150Glued at spindle poles and along astral microtubules in SIVF018
HD-NSCs transfected with shHTT50T, than in cells transfected with shControl (Fig 5A and
5B). Following the treatment of SIVF018 HD-NSCs with shHTT50T, the spindle pole signal of
NuMA was less dispersed than that in shControl-treated cells (Fig 5C).
Our results show that allele-specific silencing selectively rescues the displacement of dynein,
dynactin and NuMA. Our data suggest that allele-specific silencing rescues the phenotype of
HD cells by restoring HTT function.
Discussion
We show here that HTT interferes with the spindle orientation of human neural stem cells and
is required for the correct mitotic distribution of several key components of the spindle. We
tested the hypothesis that the heterozygous adult-onset mutations responsible for the vast
majority of cases of HD in patients result in a dominant-negative effect of the mutant-HTT on
shHTT50C: n = 67 cells were analysed. All data are from at least 3 independent experiments. Results are shown as mean values ± SEM. ***p<0.001;
Student’s t-test.
doi:10.1371/journal.pone.0148680.g004
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Fig 5. Allele-specific silencing of mutant HTT rescues dynein, p150Glued and NuMAmislocalization in human HD-NSCs. Immunostaining of shControl
and shHTT50T-treated metaphasic neural stem cells with anti-DIC (A), anti-p150Glued (B) or anti-NuMA (C) and anti-γ-tubulin antibodies. Nuclei are
counterstained with DAPI. Scale bars, 5 μm. Graphs correspond to the quantification of (A): shControl: n = 46 and shHTT50T: n = 46; (B): shControl: n = 54
and shHTT50T: n = 45; (C): shControl: n = 16 and shHTT50T: n = 28 cells analysed in at least 3 independent experiments. Results are shown as mean
values ± SEM. ***p<0.001, **p<0.01, *p<0.05; Student’s t test.
doi:10.1371/journal.pone.0148680.g005
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the function of wtHTT in correct spindle orientation and dynein, p150Glued and NuMA locali-
zation to the spindle pole and cell cortex in human mutant neural cells.
Previous studies have established a role for HTT in the regulation of molecular motors.
HTT acts as a scaffold protein for the dynein/dynactin complex in various types of dividing
and post-mitotic cells in Drosophila and mouse. This complex of HTT and microtubule-associ-
ated proteins is essential for microtubule-dependent vesicular transport in axons [9], [10],
spindle assembly and maintenance [12], and apical trafficking of the PAR-polarity complex in
mammary epithelium [29]. We show here that human HTT regulates spindle orientation in
dividing neural cells and is required for the correct localization of dynein, p150Glued and
NuMA.
We previously showed that mutHTT impairs mitotic spindle orientation and alters the
mitotic distribution of key components of the spindle. However, this interference was demon-
strated in mouse embryos or embryo-derived cells carrying two mouse mutHTT alleles with
111 CAGs (HdhQ111/Q111 knock-in mouse model) or in human cancer cells (Hela) overexpres-
sing an N-terminal fragment of human HTT with 68 CAGs [22]. The HdhQ111/Q111 knock-in
mouse model displays temporally and spatially appropriate levels ofmutHTT expression, but
both these models resemble rare and exacerbated forms of juvenile-HDmore closely than the
most common (>90% patient) adult-onset form of HD. We found that a heterozygous adult-
onset HD mutation of the HTT gene with only 46 CAGs was also able to interfere with mitotic
spindle orientation and the mitotic distribution of key components of the spindle in human
neural cells. These results are consistent with our previous report on mutant HTT interference
with the anterograde and retrograde axonal transport of BDNF vesicles in human neurons car-
rying adult-onset HDmutations [16].
The importance of asymmetric cell divisions for stem cells/progenitors has been established
in several tissues [30], [31]. In vertebrates, a correlation between spindle orientation and the
acquisition of cell fate has been proposed for the division of skin progenitors [32] and neuronal
radial glial cells (reviewed in [30], [31]). Consistent with the effect of wtHTT on spindle orien-
tation, juvenile-mutant HTT in HdhQ111/Q111 knock-in mouse affects cortical progenitor cell
division and neocortex development in mice [22]. These findings provide support for the
notion that development, particularly that of the brain, may be abnormal in HD carriers. They
are also consistent with the smaller adult intracranial brain volume measured in non-symp-
tomatic carriers of adult-onset HD mutations and the smaller head size of children at risk of
adult-onset HD [33], [34]. The demonstration that HD-iPSCs derived from somatic cells of
patients with juvenile-HD (109–180 CAGs) had significantly more nestin-expressing cells (i.e
immature progenitors) than controls after extensive neuronal differentiation in vitro is also
consistent with the occurrence of subtle neurodevelopmental defects in HD [18].
Carroll and coworkers (2011) developed antisense oligonucleotides (ASO) targeting both
exonic and intronic SNP sites that were able to decrease mutHTT levels in primary human
cells, cultured primary neurons and the adult brain of YAC18 and BACHDmice [35]. Simi-
larly, we showed that the selective degradation ofmutHTT transcripts, with the preservation of
wtHTT transcripts, could be achieved by targeting heterozygous exonic SNPs by plasmid- or
lentivirus-based transfection with a specific shRNA [16]. In HD-hESC-derivatives, used as a
cellular model of HD, we have shown that neurons derived from such hESC lines carrying
adult-onset HD mutations reproduce the defect in anterograde and retrograde BDNF vesicular
transport associated with HD [9]. This specific impairment of molecular motor function was
rescued only by silencing of themutHTT allele, with silencing of the wtHTT allele having no
effect on the mean velocity of BDNF vesicles [16]. In the study reported here, we explored the
spindle orientation dysfunction in dividing human neural cells mediated by the interference of
mutHTT with molecular motor functions. By combining more systematic gain-of-function,
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pan-allelic and allele-specific loss-of-function approaches in human cells with wild-type and
adult-onset HD alleles ofHTT, we showed that the mutHTT isoform exerted a dominant-nega-
tive effect on the role of the wtHTT protein (encoded by the wild-type allele) in molecular
motor function. The selective inactivation ofmutHTT rescued spindle abnormalities in
HD-NSCs.
In conclusion, our data confirm the relevance of neural derivatives of human pluripotent
stem cells with HD mutations for the modeling of early HD phenotypes and for explorations of
the potential of gene or drug-based therapies. We also show that the systematic use of extreme
juvenile-onset HD mutations (as opposed to the most common HDmutations giving rise to
40–50 CAGs) is both unnecessary and potentially suboptimal for modeling of the cellular dys-
functions likely to contribute to the pathological features of HD in most patients. Finally, our
data, together with previous reports of the selective (allele-specific) silencing of the mutHTT
isoform, highlight the dominant-negative activity of mutHTT and suggest that gene therapy
approaches based on the pan-allelic silencing ofHTTmay have limited therapeutic potential
because they deal only with the adverse effects due to the directly toxic activities of mutHTT,
but not the dominant-negative effects of mutHTT on wtHTT.
Supporting Information
S1 Fig. CAG repeat size and HTT expression levels in different experimental conditions.
(A) CAG repeats size detection for H9 and SIVF018 obtained using a microfluidic chip from
Agilent1 and respective sequencing showing the SNP rs362331 at exon 50. (B) Immunoblot-
ting with anti-HTT (D7F7) and anti-α-tubulin antibodies of lysates of WT-NSC cells and
WT-NSC cells treated with shHTT50T. The graph represents the quantitative assessments of
the ratio of HTT over tubulin in each condition (3 independent experiments; p<0.01). (C)
Immunoblotting with anti-HTT, NuMA, p150Glued, anti-DIC and anti-α-tubulin antibodies of
lysates of WT-NSC cells treated as indicated. The graph represents the quantitative assessments
of the ratio of the indicated proteins over tubulin in each condition (3 independent experi-
ments;  p<0.01). (D) Immunoblotting with anti-HTT (D7F7) and anti-α-tubulin antibodies
of lysates of SIVF018 cells and SIVF018 cells treated with shHTT50T. (E) Immunoblotting
with anti-HTT (1C2; recognizing the 46Q polyglutamine strech) and anti-α-tubulin antibodies
of lysates of WT-NSC, SIVF018 and SIVF018 cells treated with shHTT50T (50T).
(TIF)
S1 Table. Sequences of the oligonucleotides used to generate the shRNA targeting the SNP
and the control. The sense and anti-sense strands of the shRNA are shown in bold and the
position of the SNP in red [36].
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